1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Tiziano Frateschi
Tiziano Frateschi
Articles (1290)  | Author's Website |

5 Health Care Stocks Gurus Are Buying

Gurus are investing in these popular stocks

December 07, 2017 | About:

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Four gurus have positions in Corcept Therapeutics Inc. (NASDAQ:CORT) with a total weight of 0.13% on their portfolios.

The biotechnology company has a market cap of $1.83 billion. Its revenue grew 64% over the past 12 months and its EPS increased 625%.

The stock is trading with a price-earnings (P/E) ratio of 55.42. The current stock price of $16.07 is 21.43% below its 52-week high and 143.58% above its 52-week low. Over the past decade, it has returned a gain of 458%.

In the third quarter, Joel Greenblatt (Trades, Portfolio) added 11.39% to his position.

Four gurus are invested in Acceleron Pharma Inc. (NASDAQ:XLRN) with a combined portfolio weight of 0.17%.

The biotechnology company has a market cap of $1.59 billion. Its revenue has declined 55% over the past five years.

The current stock price of $35.06 is 12.60% below its 52-week high and 52.88% above its 52-week low. Over the past decade, it has returned a gain of 75%.

In the third quarter, Leon Cooperman (Trades, Portfolio) established a position in the company and Ron Baron (Trades, Portfolio) increased his holding by 0.32%.

Three gurus have positions in Enzymotec Ltd. (NASDAQ:ENZY).

The manufacturer of nutritional ingredients and medical foods has a market cap of $277.15 billion. The current stock price of $11.83 is 4.45% below its 52-week high and 11.85% above its 52-week low. Over the past decade, it has returned a loss of 35%.

In the third quarter, John Paulson (Trades, Portfolio) reduced his holding by 50%.

Four gurus are shareholders of Sangamo Therapeutics Inc. (NASDAQ:SGMO).

The clinical-stage biotechnology company has a market cap of $1.37 billion. The current stock price of $16.25 is 10.05% below its 52-week high and 46.46% above its 52-week low. Over the past decade, it has returned a gain of 16%.

Over the past 10 years, Sangamo Therapeutics’ revenue grew 4.80% and its EPS increased 1.60%.

Greenblatt bought 26,695 shares of the company during the third quarter.

Nine gurus are invested in Biomarin Pharmaceutical Inc. (NASDAQ:BMRN).

The biopharmaceutical company has a market cap of $14.23 billion. The current stock price of $80.75 is 19.41% below its 52-week high and 1.12% above its 52-week low. Over the past decade, it has returned a gain of 186%.

Biomarin Pharmaceutical’s revenue grew 17.70% over the past decade.

George Soros (Trades, Portfolio) exited his holding in the third quarter. Greenblatt established a position.

Disclosure: I do not own any shares of any stocks mentioned in this article.

About the author:

Tiziano Frateschi
You can read about me on this blog: www.theextraincome.info

It gives suggestions on position trading.

Visit Tiziano Frateschi's Website


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Tiziano Frateschi


User Generated Screeners


Thomas W. Eaton, Sr.Lynch - Stalwart
rael2222T
pbarker46Dividend candidates
richsmithRS Value 12/15
CarstinSingapore EV/EBIT 5.0 and belo
jmeekinsCheap Tax Reform
daftheaderNcav div
daftheaderNet net div
srichardsonGROWTH ROC FCF YIELD
rori77Roberto
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK